| dc.contributor.author | Sansacar, Merve | |
| dc.contributor.author | Sagir, Helin | |
| dc.contributor.author | Akcok, Emel Gencer | |
| dc.date.accessioned | 2021-11-27T08:57:45Z | |
| dc.date.available | 2021-11-27T08:57:45Z | |
| dc.date.issued | 2021 | en_US |
| dc.identifier.issn | 2152-2650 | |
| dc.identifier.issn | 2152-2669 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12573/1045 | |
| dc.description.abstract | Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | CIG MEDIA GROUP, LP3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | AML | en_US |
| dc.subject | acute myeloid leukemia | en_US |
| dc.subject | PI3K/AKT/mTOR pathway | en_US |
| dc.subject | histone deacetylase inhibitors | en_US |
| dc.subject | HDAC inhibitors | en_US |
| dc.subject | combination therapy | en_US |
| dc.title | Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells | en_US |
| dc.type | conferenceObject | en_US |
| dc.contributor.department | AGÜ, Yaşam ve Doğa Bilimleri Fakültesi, Biyomühendislik Bölümü | en_US |
| dc.contributor.institutionauthor | Sansacar, Merve | |
| dc.contributor.institutionauthor | Sagir, Helin | |
| dc.contributor.institutionauthor | Akcok, Emel Gencer | |
| dc.identifier.volume | Volume 21 Page S294-S294 Supplement 1 Meeting Abstract AML-240 | en_US |
| dc.relation.journal | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Başka Kurum Yazarı | en_US |
